DIETARY ADVICE
To optimise food intake
Guidance on optimising nutritional intake for your patients.
ON THIS PAGE
MALNUTRITION IN PATIENTS WITH CHRONIC CONDITIONS KEY NUTRIENTS CAN IMPROVE NUTRITIONAL STATUS AND MUSCLE HEALTH BENEFITS OF ORAL NUTRITIONAL SUPPLEMENTS FOR YOUR PATIENTS BENEFITS OF ORAL NUTRITIONAL SUPPLEMENTS FOR HEALTHCARE SERVICES CHOOSE THE RIGHT ABBOTT ONS FOR YOUR PATIENTS WITH OUR PATIENT ALGORITHM
Malnutrition risk is increased in patients living with long-term conditions.1 Malnutrition can have a significant and devastating impact on patient outcomes,1 and is one of the main risk factors for muscle loss.2-4
Many patients living with chronic conditions have insufficient food intake due to disease- and treatment-related factors such as:
Loss of appetite5-7
Early satiety5,6
Altered sense of taste and smell5-7
Disturbed GI motility, digestion and absorption7
Increased energy expenditure7
There may be different strategies for managing malnutrition, depending on the patient’s nutritional risk:*1
To optimise food intake
May be used alongside dietary advice when food intake is insufficient
When determining the correct intervention, healthcare professionals should consider the physiological changes caused by the disease itself and associated treatments that may limit the effectiveness of a food-only approach.1
For some patients with limited food intake, ONS may be considered earlier in the nutritional management strategy to minimise muscle loss, which may become irreversible without intervention.1
PROTEIN
During times of illness and in older age, protein is frequently inadequate1 however protein can help minimise the decline in muscle strength and function.8
ESPEN recommends at least 1g protein/kg body weight/day for older adults.9 For patients living with certain health conditions, this can increase up to:
VITAMIN D
Vitamin D acts directly on muscle to promote its function and can support improve skeletal muscle function.10,11 Vitamin D deficiency is linked to increased inflammation and muscle atrophy.12
ONS usage is recommended by NICE guidelines,13 and can positively influence your patients’ recovery and future outcomes:^14,15
Improve energy, protein and macronutrient intake
Reduced risk of complications
Support weight and strength
Improve quality of life
Reduce mortality risk
Prescribing malnourished patients the right ONS for adult patients at risk of malnutrition is shown to have a significant impact on healthcare resource use:16
Reduced hospital stays (21%)
Reduced risk of readmission within 30 days (6.7%)
Reduced episode cost (21.6%)
Patients with different conditions may have different nutrient deficiencies and nutritional requirements to help support their recovery - so it’s important to select the right option.
Nutritional supplements are specially formulated to support the varied dietary needs of patients with different conditions.
High protein ONS with increased vitamin D and HMB, shown to improve strength and function in malnourished patients.#17
Peptide-based ONS for patients experiencing symptoms of malabsorption.
For patients with high calorie requirements.†
For patients who require low volume.‡
Juice-style ONS for patients who don’t enjoy milkshake-style or want variety of styles**
Good compliance to ONS is essential to maximise the clinical benefit,18 and compliance improves when patients like their ONS.19
Flavour variety has a direct, positive impact on ONS compliance,20 which is why we’ve put together mixed flavour starter packs. This gives your patients the opportunity to try the whole range and request the flavours they like best.
Muscle strength and function measurements are an effective part of routine screening and are typically non-invasive, inexpensive and convenient for the patient. Early assessment and intervention is critical to improve patient outcomes
Doreen, a retired mother of two, suffered a serious fall while she was out shopping, which led to her having to spend eight weeks in hospital, recovering from a fractured neck of femur.
Doreen, a retired mother of two, suffered a serious fall while she was out shopping, which led to her having to spend eight weeks in hospital, recovering from a fractured neck of femur.
Maggie is an 83 year old female with osteoporosis and high blood presure.
Maggie is an 83 year old female with osteoporosis and high blood presure. She is housebound and lives on her own. Maggie's dietary intake was poor, so she was prescribed a powder-based oral nutritional supplement (ONS) twice daily.
Footnotes:
ONS - Oral nutritional supplement
ESPEN - European Society for Clinical Nutrition and Metabolism
COPD - Chronic obstructive pulmonary disease
GI - Gastrointestinal
*Assuming the patient can take nutrition orally.
^Studies included ready-to-consume, multi-nutrient (complete or incomplete), liquid or semi-solid products providing a mix of macronutrients and micronutrients.
#Strength and functionality were measured by handgrip strength in a post hoc analysis of over 600 malnourished people with heart or lung diseases, age 65 or older. Ensure Plus Advance was consumed twice daily for 90 days.
†E.g. younger and/or highly mobile patients who may utilise more energy in their activities of daily living.
‡Clinical conditions where a patient may require low volume include: fluid restrictions, renal disease, liver disease.
** Ensure Plus juce contains milk protein.
References:
1. Malnutrition Pathway, 2021. Managing Adult Malnutrition in the Community. Available online: https://www.malnutritionpathway.co.uk/library/managing_malnutrition.pdf Last accessed May 2025
2.Landi F et al. Clin Nutr 2019;38(5):2113-2120.
3. Argiles JM et al. JAMDA 2016;17:789-796.
4.Malnutrition Pathway, 2021. Sarcopenia: loss of muscle mass. A healthcare professional factsheet. Available online: https://www.malnutritionpathway.co.uk/library/factsheet_sarcopenia.pdf. Last accessed May 2024
5. Malnutrition Pathway. Managing malnutrition in COPD. 2023. https://www.malnutritionpathway.co.uk/library/mm_copd.pdf. Accessed December 2024.
6.Norman L et al. Nutrients. 2021;13(8):2764.
7. Arends J. Eur J Surg Oncol 2024;107074.
8.Deutz NE et al. Clin Nutr 2014;33(6):929-936.
9.Volkert D et al. Clin Nutr 2019;38(1):10-47.
10. Wagatsuma A. and Sakuma K. Biomed Res Int 2014;2014:121254.2.Landi F et al. Clin Nutr 2019;38(5):2113-2120.
11. European Food Safety Authority. EFSA J 2011;9(9):2382.
12.Dzik KP & Kaczor JJ. Eur J Appl Physiol 2019;119:825-839.
13. NICE. Nutrition support for adults. 2017. Available online https://www.nice.org.uk/guidance/cg32/resources/nutrition-support-for-adults-oral-nutrition-support-enteral-tube-feeding-and-parenteral-nutrition-pdf-975383198917 (Last accessed July 2025)
14.Elia M et al. Clin Nutr 2016;35:370-380.
15. Elia M et al. Clin Nutr 2016;35:125-137.
16.Philipson TJ et al. American Journal of Managed Care. 2013; 19(2):121-128.
17.Matheson EM et al. Clin Nutr 2021;40(3):844-849.
18.Nelson JL. Clin Nutr Exp. 2019;28:123-130.
19. Lester S et al. J Nutr Health Aging. 2022;26(7):663-674.
20.Hubbard GP et al. Clin Nutr. 2012;31(3):293-312.
SESSION TIMEOUT
You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.
You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.
Added to Bag
ENSURE PLUS
1 x 220 ml
Flavor: Apple
1,5 kcal / ml
Nutrition Information
Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
Unit | Per {ml-col-1} ml | Per {ml-col-2} ml |
footnotes
Product details not available.
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
This website is for UK HCPs and UK Patients only. If you are outside of the UK please visit our global website Abbott.com
If you choose "I am a patient/carer”, you will be entering a website intended for patients and carers which has information on Abbott products. Products on this website are to be used under medical supervision. If you have questions about the product information discussed on this website, you should consult with your healthcare professional.
Stay Connected